Association of Clinical Symptoms with Biochemical and Hematological Findings in Patients with Tuberculosis.
Keywords:
Pulmonary Tuberculosis, clinical symptoms, reduced apatite, weight loss, hematological parametersAbstract
Objective: Tuberculosis (TB) is a key health issue and is characterized by a wide variety of clinical symptoms which can be affected by the underlying biochemical and hematological status of the patients. Therefore, this study assessed the association of clinical symptoms with biochemical and hematological findings among patients with tuberculosis.
Methodology: This cross-sectional experimental study was conducted in institute of Basic Medical Sciences (IBMS), Khyber Medical University. A total of 103 patients aged ≥15 years suspected with pulmonary tuberculosis, were included in the study. A chi-square test and Fisher’s exact test was used to observe the association between clinical symptoms and demographics, hematological, and biochemical findings. Additionally, a Mann Whitney test was employed to analyze the relationship between the means of demographic variables.
Results: The study findings showed that all patients reported cough, and 100 (97.1%) had fever, with no significant association between symptoms and demographics, comorbidities, medication use, or hematological markers such as TLC and ESR (p>0.05). Significant associations were found with diabetes, where weight loss 48 (55.2%) (p=0.032) and reduced appetite (p=0.002) were more common among diabetics. Reduced appetite was also significantly linked to fasting blood sugar levels (p=0.017) and chronic illness (p=0.020), while all other variables showed no significant associations.
Conclusion: This study concluded that comorbid diabetes and chronic illnesses were significantly associated with main clinical symptoms, such as weight loss and reduced appetite. A significant association was identified between fasting blood sugar levels and reduced appetite. In contrast, hematological parameters including Total Leukocyte Count (TLC) and Erythrocyte Sedimentation Rate (ESR), showed no significant association with clinical symptoms
Downloads
References
1.WHO consolidated guidance on tuberculosis data generation and use. Module 1. Tuberculosis surveillance. Geneva: World Health Organization; 2024(https://iris.who.int/handle/10665/376612). Licence: CC BY-NC-SA 3.0 IGO.
2. Jawad M, Bilal A, Khan S, Rizwan M, Arshad M. Prevalence and awareness survey of tuberculosis in the suspected population of Bajaur Agency in Fata, Pakistan: Prevalence and awareness survey of tuberculosis. Pakistan Journal of Health Sciences. 2023 Jun 30:56-61. https://doi.org/10.54393/pjhs.v4i06.793
3. Khalid N, Ahmad F, Qureshi FM. Association amid the comorbidity of Diabetes Mellitus in patients of Active Tuberculosis in Pakistan: A matched case control study. Pakistan Journal of Medical Sciences. 2021 May;37(3):816-820. 10.12669/pjms.37.3.3274
4. Awan HA, Sahito AM, Sukaina M, Khatri G, Waheed S, Sohail F, et.al. Tuberculosis amidst COVID-19 in Pakistan: a massive threat of overlapping crises for the fragile healthcare systems. Epidemiology & Infection. 2022 Jan;150:e41. doi:10.1017/S0950268822000358
5. World Health Organization. Guidelines on the management of latent tuberculosis infection. Geneva: World Health Organization; 2015. 38 p. (WHO/HTM/TB/2015.01). ISBN: 9789241548908.
6. Centers for Disease Control and Prevention. Clinical overview of tuberculosis for health care providers. Atlanta (GA): CDC; 2025 Jan 6.
7. World Health Organization. WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis – Rapid diagnostics for tuberculosis detection. Geneva: World Health Organization; 2022. 84 p. ISBN: 9789240007307.
8. 2024 TB Breakthrough: New National Guidelines Revolutionize Treatment, Diagnosis & Prevention – A Comprehensive Guide. Punjab Tuberculosis Control Programme; 2024.
9. Farhadian M, Veisi S, Farhadian N, Zamanian MH. Hematological parameters in newly diagnosed TB patients: a systematic review and meta-analysis. Tuberculosis. 2024 Jan 1;144:102430. https://doi.org/10.1016/j.tube.2023.102430
10. Tiu DN, Ahmed SM, Ranjan R, Siddiqi F. Hematological Changes in Pulmonary Tuberculosis: Focus on Anemia, Disease Severity, and Therapeutic Implications. Cureus. 2025 Jun 22;17(6). https://doi.org/10.7759/cureus.86550
11. Batool Y, Pervaiz G, Arooj A, Fatima S. Hematological manifestations in patients newly diagnosed with pulmonary tuberculosis. Pakistan Journal of Medical Sciences. 2022 Sep;38(7):1968. doi: https://doi.org/10.12669/pjms.38.7.5911
12. The Haematological Profile of Patients of Pulmonary. Ann of Pathol and Lab Med [Internet]. 2019 Nov. 1 [cited 2025 Dec. 10];6(10): A515-518. https://pacificejournals.com/journal/index.php/apalm/article/view/2438
13. Association between Pulmonary Tuberculosis and Hematological Alterations: A Case-Control Study. AJBR [Internet]. 2020 Feb. 6 [cited 2025 Dec. 10];23(1):07-14. https://africanjournalofbiomedicalresearch.com/index.php/AJBR/article/view/8570
14. Hematological Changes in Patients Presenting with Pulmonary Tuberculosis. mfm [Internet]. 2024 May 19 [cited 2025 Dec. 10];28(5). https://medicalforummonthly.com/index.php/mfm/article/view/4080
15. Shah AR, Desai KN, Maru AM. Evaluation of hematological parameters in pulmonary tuberculosis patients. Journal of family medicine and primary care. 2022 Aug 1;11(8):4424-8. https://doi.org/10.4103/jfmpc.jfmpc_2451_21
16. Ongwae JM, Musyoki SK, Mongare S. Profile of haematological indices among pulmonary tuberculosis patients attending Kisii teaching and referral hospital, Kenya. Int J Community Med Public Health [Internet]. 2023 Jul. 29 [cited 2025 Dec. 10];10(8):2669-75. https://www.ijcmph.com/index.php/ijcmph/article/view/11523
17. Nyamagoud SB, Dsouza PD, Chitralu SP, Solankure K, Swamy AH. Evaluating hematological and inflammatory biomarkers in tuberculosis management. Monaldi Archives for Chest Disease. 2025 Jul 30. https://doi.org/10.4081/monaldi.2025.3433
18. Zhang Y, Gai X, Rao Y, Qu J, Sheng Z, Li D, et,al. Pre-treatment blood cell counts and inflammatory markers predict the radiologic severity of post-tuberculosis lung disease. BMC Infectious Diseases. 2025 Oct 22;25(1):1384. https://doi.org/10.1186/s12879-025-11782-w.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
